NVAX
Novavax Inc
Price:  
8.19 
USD
Volume:  
2,445,680.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Novavax Fair Value

-208.57 %
Upside

As of 2025-02-19, the Fair Value of Novavax Inc (NVAX) is -8.89 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.19 USD, the upside of Novavax Inc is -208.57%.

Note: valuation result may not be accurate due to the company's negative EPS.

8.19 USD
Stock Price
-8.89 USD
Fair Price
FAIR VALUE CALCULATION

Novavax Fair Value

Peter Lynch's formula is:

Novavax Fair Value
= Earnings Growth Rate x TTM EPS
Novavax Fair Value
= 5.00 x -1.78
Novavax Fair Value
= -8.89

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -132.70 -418.30 -1,743.80 -657.90 -545.06 -699.55
YoY growth 28.15% -215.22% -316.88% 62.27% 17.15% -84.90%

Novavax Fair Value - Key Data

Market Cap (mil) 1,311.87
P/E
Forward P/E
EPS -1.78
Avg earnings growth rate -84.90%
TTM earnings -284.86